Skip to main content

Chart: Massachusetts Recreational Marijuana Sales Soar In First Month Despite Obstacles

Massachusetts dispensaries rang up $9.3 million in recreational marijuana sales during the first four weeks of operation, an impressive feat considering only two stores were selling adult-use cannabis during the bulk of this period.

Compared with the first month of rec sales in other states, Massachusetts had lower gross sales but far fewer operating dispensaries than Oregon ($14 million, 320 dispensaries), Colorado ($14.7 million, 59 dispensaries) and Nevada ($27.1 million, 53 dispensaries).

The two Massachusetts dispensaries – Cultivate in Leicester and New England Treatment Access (NETA) in Northampton – took in more than $440,000 on the first day of sales, and the state averaged $2.3 million in sales per week.

Alternative Therapies Group (ATG) opened Dec. 15 in Salem.

Two more dispensaries – Verilife in Wareham and Insa in Easthampton – were approved to commence recreational sales in late December, with several other dispensaries slated for approval in the new year.

Another hurdle for the market: Sales began Nov. 20 – a Tuesday – and were halted that Thursday for Thanksgiving, abbreviating the first week to five days.

The operating dispensaries also took the unique step of limited per-person transactions below the state’s legal 1-ounce purchasing limit to prevent product shortages.

ATG went a step further, requiring adult-use customers to make an appointment to visit the dispensary.

The Marijuana Business Factbook 2018 estimates that Massachusetts has 900,000 to 1.1 million in-state customers.

And, as the first Eastern state to begin legal adult-use sales, Massachusetts is expected to benefit from the region’s population density.

The state is on pace to break $14 million in recreational sales in 2018.

Here’s what else you need to know:

  • Through Dec. 16, Massachusetts sold 234,656 individual units of recreational marijuana products. The state’s Cannabis Control Commission (CCC) defines a unit as an individual product, such as a package of edibles, container of measured marijuana or bottle of lotion.
  • The state has not set caps on the number of recreational facilities allowed. As of Dec. 16, the CCC had received a total of 224 complete applications. Of those, 13 businesses received their final licenses and 11 had commenced operations, including five retailers, two cultivators, two testing laboratories and two product manufacturers.
  • Medical marijuana dispensaries continue to open. While the state has allowed for unlimited recreational businesses, licensing priority is given to experienced medical dispensaries. The Massachusetts Medical Use of Marijuana Program had more than 57,000 active patients and 47 registered dispensaries as of Nov. 30.

Maggie Cowee can be reached at [email protected]

Eli McVey can be reached at [email protected]

Original Article Source: https://mjbizdaily.com/massachusetts-recreational-marijuana-sales-first-month/

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...